A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Elicio Therapeutics
Shanghai Bao Pharmaceuticals Co., Ltd.
Tempus AI
Elevation Oncology
Intensity Therapeutics, Inc.
Carisma Therapeutics Inc
UTC Therapeutics Inc.
Celldex Therapeutics
Chongqing Precision Biotech Co., Ltd
Klus Pharma Inc.
Xencor, Inc.
MacroGenics
SpeciCare
INSYS Therapeutics Inc